STAT3 and lip and oral cavity carcinoma: Mechanistically, it was revealed that STAT3 closely regulated inflammation in oral cancer cells, and the use of stattic significantly compromised the inhibitory effects of IL-37 on the growth of oral cancer cells and the promotive effects on apoptosis.